Title:
NEW USE OF ANGIOTENSIN II RECEPTOR AGONISTS
Document Type and Number:
WIPO Patent Application WO/2016/107879
Kind Code:
A3
Abstract:
This invention relates to a new use of compounds that are angiotensin II (Ang II) receptor agonists, more particularly agonists of the Ang II type 2 receptor (the AT2 receptor), and especially non-peptide agonists that bind selectively to the AT2 receptor, for adjuvant administration in stem cell and progenitor cell therapy.
More Like This:
Inventors:
DAHLÖF BJÖRN (SE)
LJUNGGREN ANDERS (SE)
LEUNG PO SING (CN)
LJUNGGREN ANDERS (SE)
LEUNG PO SING (CN)
Application Number:
PCT/EP2015/081369
Publication Date:
August 25, 2016
Filing Date:
December 29, 2015
Export Citation:
Assignee:
VICORE PHARMA AB (SE)
International Classes:
A61K31/401; A61K31/4178; A61P43/00
Domestic Patent References:
WO2006109058A1 | 2006-10-19 | |||
WO2004085420A1 | 2004-10-07 | |||
WO1999040107A2 | 1999-08-12 | |||
WO1999026644A1 | 1999-06-03 | |||
WO2012070936A1 | 2012-05-31 |
Foreign References:
US6248587B1 | 2001-06-19 | |||
US20120035232A1 | 2012-02-09 |
Attorney, Agent or Firm:
AROS PATENT AB (Uppsala, SE)
Download PDF: